BioCentury | Aug 21, 2006
Strategy
Targeted Genetics chronicles
...11/00 - Says it will spin out its cell therapy technology into a subsidiary called CellExSys...
...improvements in pulmonary function in a Phase II trial in CF (p=0.04) O. 10/10/02 - CellExSys...
...improvements in pulmonary function in a Phase II trial in CF (p=0.04) O. 10/10/02 - CellExSys...